Free Trial

Alliance Pharma (LON:APH) Stock Price Passes Above 200 Day Moving Average - Should You Sell?

Alliance Pharma logo with Medical background

Alliance Pharma plc (LON:APH - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 38.97 ($0.50) and traded as high as GBX 48.16 ($0.62). Alliance Pharma shares last traded at GBX 46.05 ($0.59), with a volume of 1,635,042 shares traded.

Alliance Pharma Price Performance

The business has a 50-day moving average price of GBX 43.91 and a two-hundred day moving average price of GBX 39.02. The company has a market capitalization of £252.45 million, a price-to-earnings ratio of -782.40, a price-to-earnings-growth ratio of 1.04 and a beta of 0.67. The company has a quick ratio of 1.42, a current ratio of 2.93 and a debt-to-equity ratio of 47.46.

Alliance Pharma Company Profile

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Further Reading

Should you invest $1,000 in Alliance Pharma right now?

Before you consider Alliance Pharma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alliance Pharma wasn't on the list.

While Alliance Pharma currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025
’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines